These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 190074)

  • 41. Differential effects of oral, peripheral intravenous, and intraportal glucose on hepatic glucose uptake and insulin and glucagon extraction in conscious dogs.
    Ishida T; Chap Z; Chou J; Lewis R; Hartley C; Entman M; Field JB
    J Clin Invest; 1983 Aug; 72(2):590-601. PubMed ID: 6348094
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes.
    Brismar K; Fernqvist-Forbes E; Wahren J; Hall K
    J Clin Endocrinol Metab; 1994 Sep; 79(3):872-8. PubMed ID: 7521354
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hyperglucagonemia and insulin-mediated glucose metabolism.
    Del Prato S; Castellino P; Simonson DC; DeFronzo RA
    J Clin Invest; 1987 Feb; 79(2):547-56. PubMed ID: 3543054
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of sequential infusions of glucagon and epinephrine on glucose turnover in the dog.
    Saccà L; Sherwin R; Felig P
    Am J Physiol; 1978 Sep; 235(3):E287-90. PubMed ID: 696823
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanisms of hyperinsulinemia and hyperglucagonemia after liver transplantation.
    Sika M; Blair KT; Jabbour K; Williams PE; Donovan KL; Drougas JG; Becker YT; Bradley AL; Van Buren DH; Flakoll PJ; Chapman WC; Wright JK; Pinson CW
    J Surg Res; 1997 Jul; 70(2):144-50. PubMed ID: 9245563
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production.
    Toft I; Jenssen T
    Scand J Clin Lab Invest; 2005; 65(4):307-20. PubMed ID: 16076686
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects.
    Groop L; Luzi L; Melander A; Groop PH; Ratheiser K; Simonson DC; DeFronzo RA
    Diabetes; 1987 Nov; 36(11):1320-8. PubMed ID: 3117609
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Abnormal secretion of insulin and glucagon by the in vitro perfused pancreas of the genetically diabetic Chinese hamster.
    Frankel BJ; Gerich JE; Hagura R; Fanska RE; Gerritsen GC; Grodsky GM
    J Clin Invest; 1974 Jun; 53(6):1637-46. PubMed ID: 4830228
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glucose disposal during insulinopenia in somatostatin-treated dogs. The roles of glucose and glucagon.
    Shulman GI; Liljenquist JE; Williams PE; Lacy WW; Cherrington AD
    J Clin Invest; 1978 Aug; 62(2):487-91. PubMed ID: 670404
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of glucose production by NEFA and gluconeogenic precursors during chronic glucagon infusion.
    McGuinness OP; Ejiofor J; Audoly LP; Schrom N
    Am J Physiol; 1998 Sep; 275(3):E432-9. PubMed ID: 9725809
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects.
    Palmer JP; Benson JW; Walter RM; Ensinck JW
    J Clin Invest; 1976 Sep; 58(3):565-70. PubMed ID: 783201
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of somatostatin on splanchnic glucose metabolism in postabsorptive and 60-hour fasted humans.
    Wahren J; Efendić S; Luft R; Hagenfeldt L; Björkman O; Felig P
    J Clin Invest; 1977 Feb; 59(2):299-307. PubMed ID: 833277
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of low-dose dopamine infusion on insulin and glucagon release in fasting normal man.
    Connell JM; Beastall GH; Davies DL; Buchanan K
    Horm Metab Res; 1986 Jan; 18(1):67-8. PubMed ID: 3512396
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Beta-adrenergic contribution to glucagon-induced glucose production and insulin secretion in uremia.
    Baylor P; Shilo S; Zonszein J; Shamoon H
    Am J Physiol; 1986 Sep; 251(3 Pt 1):E322-7. PubMed ID: 3019152
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential sensitivity of glycogenolysis and gluconeogenesis to insulin infusions in dogs.
    Chiasson JL; Liljenquist JE; Finger FE; Lacy WW
    Diabetes; 1976 Apr; 25(4):283-91. PubMed ID: 1269837
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of hyperglucagonemia on hepatic glycogenolysis and gluconeogenesis after a prolonged fast.
    Hendrick GK; Frizzell RT; Williams PE; Cherrington AD
    Am J Physiol; 1990 May; 258(5 Pt 1):E841-9. PubMed ID: 2185665
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Superior efficacy of pulsatile versus continuous hormone exposure on hepatic glucose production in vitro.
    Komjati M; Bratusch-Marrain P; Waldhäusl W
    Endocrinology; 1986 Jan; 118(1):312-9. PubMed ID: 3000741
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of an acute elevation of NEFA concentrations on glucagon-stimulated hepatic glucose output.
    Everett-Grueter C; Edgerton DS; Donahue EP; Vaughan S; Chu CA; Sindelar DK; Cherrington AD
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E449-59. PubMed ID: 16608886
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Control of insulin secretion during fasting hyperglycemia in adult diabetics and in nondiabetic subjects during infusion of glucose.
    Goodner CJ; Conway MJ; Werbach JH
    J Clin Invest; 1969 Oct; 48(10):1878-87. PubMed ID: 5822593
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A decreased response of cyclic adenosine monophosphate concentrations to glucagon in liver slices from streptozotocin-induced diabetic rats.
    Yamashita K; Yamashita S; Yasuda H; Oka Y; Ogata E
    Diabetes; 1980 Mar; 29(3):188-92. PubMed ID: 6247231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.